Biostimulators work by triggering the body’s own collagen production rather than adding immediate volume. Results develop over 2–6 months and last 18 months to 4 years depending on the product. Korean clinics are among the highest-volume biostimulator providers globally — particularly for Sculptra and Re2O — with pricing 50–65% below US rates.
Price by product
| Product | Unit | Korea (KRW) | Korea (USD) | USA (USD) | Korea saving |
|---|---|---|---|---|---|
| Sculptra (PLLA) | Per vial | ₩500,000–₩1,000,000 | $362–$725 | $800–$1,200 | ~50% less |
| Radiesse (CaHA) | Per syringe (1.5ml) | ₩300,000–₩700,000 | $217–$507 | $600–$1,000 | ~50% less |
| Ellansé (PCL) | Per syringe (1ml) | ₩400,000–₩900,000 | $290–$652 | N/A (not FDA approved) | — |
| Gouri (PCL liquid) | Per session | ₩400,000–₩800,000 | $290–$580 | N/A (not approved) | — |
| Re2O (PN + HA) | Per session | ₩500,000–₩1,200,000 | $362–$870 | N/A (Korea-only) | — |
Full course cost estimates
| Product | Typical course | Total course (KRW) | Total (USD approx) |
|---|---|---|---|
| Sculptra | 4 vials over 2 sessions | ₩2,000,000–₩4,000,000 | $1,449–$2,899 |
| Radiesse | 2–3 syringes over 1–2 sessions | ₩600,000–₩2,100,000 | $435–$1,522 |
| Ellansé | 1–2 syringes per session | ₩400,000–₩1,800,000 | $290–$1,304 |
| Gouri | 2–3 sessions | ₩800,000–₩2,400,000 | $580–$1,739 |
| Re2O | 1–2 sessions | ₩500,000–₩2,400,000 | $362–$1,739 |
How many vials of Sculptra do I need and what does the full course cost?
Sculptra vial count depends on the degree of volume loss and areas being treated. A common approach is 1 vial per decade of age per session, typically 2–3 vials over 2–3 sessions. At ₩500,000–₩1,000,000 per vial, a 2-session, 4-vial course costs ₩2,000,000–₩4,000,000 ($1,449–$2,899 USD). Compare to $800–$1,200 per vial in the US — the Korean saving is roughly 50% on product cost.
What is Re2O and why is it only available in Korea?
Re2O is a next-generation collagen biostimulator containing polynucleotides and cross-linked hyaluronic acid, developed and manufactured in Korea. It is not yet approved in the US, EU, or Australia. Korean clinics use it for skin quality improvement and early structural support, positioned between a skin booster and a traditional biostimulator. The lack of international availability makes Korea the only place to access it at present.
Is Ellansé available in Korea and how does it compare to Sculptra?
Ellansé is available at selected Korean clinics. It is a poly-caprolactone (PCL) biostimulator — different from Sculptra (poly-L-lactic acid, PLLA) — with more immediate volume effect and longer duration (2–4 years depending on formulation). At ₩400,000–₩900,000 per syringe versus £700–£1,200 in the UK, the Korean saving is approximately 50%. Ellansé is not FDA-approved in the US, making Korea and the UK the most accessible markets.